Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Sep. 30, 2021
Mar. 31, 2021
Current assets:    
Cash and cash equivalents $ 8,392 $ 4,220
Accounts receivable, net 3,416 2,806
Inventories, net 2,482 2,530
Prepaid expenses and other current assets 3,519 3,218
Current portion of deferred consideration, net of discount 212 209
Total current assets 18,021 12,983
Property and equipment, net 337 360
Operating lease, right of use assets 700 769
Deferred consideration, net of discount, less current portion 694 763
Other assets 76 112
Total assets 19,828 14,987
Current liabilities:    
Accounts payable 1,876 1,769
Accrued expenses and other current liabilities 987 1,154
Deferred revenue 100 267
Deferred revenue Invekra 53 52
Current portion of debt – PPP 587 0
Current portion of long-term debt 199 596
Operating lease liabilities 276 240
Total current liabilities 4,078 4,078
Long-term deferred revenue Invekra 205 229
Long-term debt, less current portion – PPP 0 1,310
Withholding tax payable 3,661 3,478
Operating lease liabilities, less current portion 424 529
Total liabilities 8,368 9,624
Commitments and Contingencies (Note 6) $ 0 $ 0
Stockholders’ Equity:    
Series C Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at September 30, 2021 and March 31, 2021, 0 shares issued and outstanding at September 30, 2021 and March 31, 2021 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized September 30, 2021 and March 31, 2021, 3,004,741 and 2,092,909 shares issued and outstanding at September 30, 2021 and March 31, 2021, respectively (Note 9) $ 3 $ 2
Additional paid-in capital 196,438 189,217
Accumulated deficit (180,475) (179,277)
Accumulated other comprehensive loss (4,506) (4,579)
Total stockholders’ equity 11,460 5,363
Total liabilities and stockholders’ equity $ 19,828 $ 14,987